SOPHARMA USA CORPORATION

CARSIL

pharmaceutical preparation for the treatment of toxic, metabolic and degenerative diseases of the hepatic parenchyma;

CLENBUTEROL

pharmaceutical preparation for stimulating the beta-2-adrenoreceptors of the bronchopulmonary system with direct myotropic action on the bronchial musculature; catabolic to fat and anabolic to muscle tissue;

CLINOGEL

pharmaceutical preparation functioning as an adstringent and anti-inflammatory medicament; used as medical and balneologic treatment for skin protection and regeneration of skin after sunburn, and for treating acne;CLINO GEL;

ESCULIN

pharmaceuitical preparation constituting a coumarin derivative extracted from the bark of flowering ash and possessing an action similar to vitamin;chemical for use in the manufacture of pharmaceuticals with venotonic, capillary-strengthening and antiphlogistic action;

PALMCAROTENOL

pharmaceutical preparation used as a nutritional supplement for improving and regulating the metabolism in the epithelial cells, protecting them from degenerative alterations, and enhances and maintains the status of the immune system;PALM CAROTENOL;

PEFLAVIT

pharmaceutical preparation for enhancing the resistance of the capillary wall and reduce its intensified permeability;

PHYTIN

pharmaceutical preparation for improving appetite and accelerating the course of healing process; stimulates the production of red blood cells from bone marrow; has a tonic effect on the nervous system; improves building of bone tissue;

PYMADIN

pharmaceutical preparation for treatment of peripheral neuritis and neuralgia and treatment of neurological disorders including multiple sclerosis, myasthenia gravis, congenital myasthenia, eaton-lampert syndrome, spinal cord injury, verapamil overdose, alzheimer's disease and botulism;

S SOPHARMA

pharmaceutical preparations, namely, nicotine supplements for use by smokers to aid in the cessation of smoking; cough syrups; pharmaceutical preparation, namely, extract from yellow horned poppy having antitussive action; food supplements, namely, nonhormonal phytochemical biostimulator, extract of dry Valeriana officinalis L, protein synthesis stimulators, extract from bar of flowering ash, galanthimine bromide and flavonoids;SOPHARMA;

TABEX

pharmaceutical preparation which promotes a gradual reduction and elimination of existing psychic nicotine dependence in smokers;

VALERIANA

pharmaceutical preparation that reduces the excitability of the nervous system, enhances the action of soporifics and also possesses spasmolytic properties;chemical for use in the manufacture of pharmaceuticals;